Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Valvular Heart Disease

Free Subscription Articles published in PLoS One Retrieve available abstracts of 70 articles: HTML format Text format

Single Articles

January 2018
1. FREYTSIS M, Baugh L, Liu Z, Georgakoudi I, et al
   Conditional deletion of RB1 in the Tie2 lineage leads to aortic valve regurgitation.
   PLoS One. 2018;13:e0190623.
   PubMed     Text format     Abstract available
   
   
   
2. SCHAEFER A, Dickow J, Schoen G, Westhofen S, et al
   Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis.
   PLoS One. 2018;13:e0191171.
   PubMed     Text format     Abstract available
   
   
   
3. PUJADES-RODRIGUEZ M, Guttmann OP, Gonzalez-Izquierdo A, Duyx B, et al
   Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records.
   PLoS One. 2018;13:e0191214.
   PubMed     Text format     Abstract available
   
   
   
4. ZHAI S, Xu H, Fan C, Yang Y, et al
   Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy.
   PLoS One. 2018;13:e0192218.
   PubMed     Text format     Abstract available
   
   
   
5. BORGEAT K, Niessen SJM, Wilkie L, Harrington N, et al
   Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease.
   PLoS One. 2018;13:e0194342.
   PubMed     Text format     Abstract available
   
   
   
6. CASQUEL DE TOMASI L, Salome Campos DH, Grippa Sant'Ana P, Okoshi K, et al
   Pathological hypertrophy and cardiac dysfunction are linked to aberrant endogenous unsaturated fatty acid metabolism.
   PLoS One. 2018;13:e0193553.
   PubMed     Text format     Abstract available
   
   
   
7. WURSCHINGER F, Wittmann S, Goldfuss S, Zech N, et al
   Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia.
   PLoS One. 2018;13:e0193558.
   PubMed     Text format     Abstract available
   
   
   
8. ORTIZ-ROMERO P, Borralleras C, Bosch-Morato M, Guivernau B, et al
   Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model.
   PLoS One. 2018;13:e0194476.
   PubMed     Text format     Abstract available
   
   
   January 2017
9. GREER JM, Hamilton C, McMullon ME, Riby DM, et al
   An event related potential study of ihibitory and attentional control in Williams syndrome adults.
   PLoS One. 2017;12:e0170180.
   PubMed     Text format     Abstract available
   
   
   
10. SONG I, Ko SM, Yi JG, Chee HK, et al
    Differences in Aortic Valve and Left Ventricular Parameters Related to the Severity of Myocardial Fibrosis in Patients with Severe Aortic Valve Stenosis.
    PLoS One. 2017;12:e0170939.
    PubMed     Text format     Abstract available
    
    
    
11. WANG YT, Tao J, Maimaiti A, Adi D, et al
    Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China.
    PLoS One. 2017;12:e0174490.
    PubMed     Text format     Abstract available
    
    
    
12. MARTINS CO, Demarchi L, Ferreira FM, Pomerantzeff PM, et al
    Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.
    PLoS One. 2017;12:e0170191.
    PubMed     Text format     Abstract available
    
    
    
13. MADEMONT-SOLER I, Mates J, Yotti R, Espinosa MA, et al
    Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0181465.
    PubMed     Text format     Abstract available
    
    
    
14. CASOS K, Ferrer-Curriu G, Soler-Ferrer P, Perez ML, et al
    Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox status.
    PLoS One. 2017;12:e0174588.
    PubMed     Text format     Abstract available
    
    
    
15. TOPPEN W, Johansen D, Sareh S, Fernandez J, et al
    Improved costs and outcomes with conscious sedation vs general anesthesia in TAVR patients: Time to wake up?
    PLoS One. 2017;12:e0173777.
    PubMed     Text format     Abstract available
    
    
    
16. MASCHERBAUER J, Kammerlander AA, Zotter-Tufaro C, Aschauer S, et al
    Presence of isolated tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction.
    PLoS One. 2017;12:e0171542.
    PubMed     Text format     Abstract available
    
    
    
17. LEE SY, Shim CY, Hong GR, Cho IJ, et al
    Determinants and Prognostic Significance of Symptomatic Status in Patients with Moderately Dysfunctional Bicuspid Aortic Valves.
    PLoS One. 2017;12:e0169285.
    PubMed     Text format     Abstract available
    
    
    
18. DHARMARAJAN K, Foster J, Coylewright M, Green P, et al
    The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers.
    PLoS One. 2017;12:e0175926.
    PubMed     Text format     Abstract available
    
    
    
19. KOLASA-TRELA R, Konieczynska M, Bazanek M, Undas A, et al
    Specific changes in circulating cytokines and growth factors induced by exercise stress testing in asymptomatic aortic valve stenosis.
    PLoS One. 2017;12:e0173787.
    PubMed     Text format     Abstract available
    
    
    
20. THONGPRAYOON C, Cheungpasitporn W, Thamcharoen N, Ungprasert P, et al
    Association of frailty status with acute kidney injury and mortality after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0177157.
    PubMed     Text format     Abstract available
    
    
    
21. TSUJI M, Kawasaki T, Matsuda T, Arai T, et al
    Sexual dimorphisms of mRNA and miRNA in human/murine heart disease.
    PLoS One. 2017;12:e0177988.
    PubMed     Text format     Abstract available
    
    
    
22. GUERBAII RA, Fustier G, Ennezat PV, Ringle A, et al
    Asymptomatic aortic stenosis: An assessment of patients' and of their general practitioners' knowledge, after an indexed specialized assessment in community practice.
    PLoS One. 2017;12:e0178932.
    PubMed     Text format     Abstract available
    
    
    
23. WANG J, Chandrasekhar V, Abbadessa G, Yu Y, et al
    In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0178905.
    PubMed     Text format     Abstract available
    
    
    
24. VASSILIOU VS, Flynn PD, Raphael CE, Newsome S, et al
    Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance.
    PLoS One. 2017;12:e0181077.
    PubMed     Text format     Abstract available
    
    
    
25. MCNAMARA JW, Li A, Lal S, Bos JM, et al
    MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0180064.
    PubMed     Text format     Abstract available
    
    
    
26. AUENSEN A, Hussain AI, Falk RS, Walle-Hansen MM, et al
    Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis.
    PLoS One. 2017;12:e0179304.
    PubMed     Text format     Abstract available
    
    
    
27. GUO X, Fan C, Tian L, Liu Y, et al
    The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.
    PLoS One. 2017;12:e0174118.
    PubMed     Text format     Abstract available
    
    
    
28. MENDES DE ALMEIDA R, Tavares J, Martins S, Carvalho T, et al
    Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy.
    PLoS One. 2017;12:e0182946.
    PubMed     Text format     Abstract available
    
    
    
29. ZHANG S, Kolominsky-Rabas PL
    How TAVI registries report clinical outcomes-A systematic review of endpoints based on VARC-2 definitions.
    PLoS One. 2017;12:e0180815.
    PubMed     Text format     Abstract available
    
    
    
30. FUKUMOTO R, Kawai M, Minai K, Ogawa K, et al
    Conflicting relationship between age-dependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide.
    PLoS One. 2017;12:e0181206.
    PubMed     Text format     Abstract available
    
    
    
31. TEMU TM, Lane KA, Shen C, Ng'ang'a L, et al
    Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya.
    PLoS One. 2017;12:e0185204.
    PubMed     Text format     Abstract available
    
    
    
32. SONG Y, Soh S, Shim JK, Park KU, et al
    Skin perfusion pressure as an indicator of tissue perfusion in valvular heart surgery: Preliminary results from a prospective, observational study.
    PLoS One. 2017;12:e0184555.
    PubMed     Text format     Abstract available
    
    
    
33. ELATTAR MA, Vink LW, van Mourik MS, Baan J Jr, et al
    Dynamics of the aortic annulus in 4D CT angiography for transcatheter aortic valve implantation patients.
    PLoS One. 2017;12:e0184133.
    PubMed     Text format     Abstract available
    
    
    
34. DI FRANCO A, Kim J, Rodriguez-Diego S, Khalique O, et al
    Multiplanar strain quantification for assessment of right ventricular dysfunction and non-ischemic fibrosis among patients with ischemic mitral regurgitation.
    PLoS One. 2017;12:e0185657.
    PubMed     Text format     Abstract available
    
    
    
35. MARTINEZ-VARGAS J, Ventura J, Machuca A, Munoz-Munoz F, et al
    Cardiac, mandibular and thymic phenotypical association indicates that cranial neural crest underlies bicuspid aortic valve formation in hamsters.
    PLoS One. 2017;12:e0183556.
    PubMed     Text format     Abstract available
    
    
    
36. PETZOLDT M, Trepte CJ, Ridder J, Maisch S, et al
    Reliability of transcardiopulmonary thermodilution cardiac output measurement in experimental aortic valve insufficiency.
    PLoS One. 2017;12:e0186481.
    PubMed     Text format     Abstract available
    
    
    
37. ORLOWSKA-BARANOWSKA E, Gadomska Vel Betka L, Gora J, Baranowski R, et al
    Functional polymorphism of the renalase gene is associated with cardiac hypertrophy in female patients with aortic stenosis.
    PLoS One. 2017;12:e0186729.
    PubMed     Text format     Abstract available
    
    
    
38. LUNATI ME, Bedeschi MF, Resi V, Grancini V, et al
    Impaired glucose metabolism in subjects with the Williams-Beuren syndrome: A five-year follow-up cohort study.
    PLoS One. 2017;12:e0185371.
    PubMed     Text format     Abstract available
    
    
    
39. VISWANATHAN SK, Sanders HK, McNamara JW, Jagadeesan A, et al
    Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
    PLoS One. 2017;12:e0187948.
    PubMed     Text format     Abstract available
    
    
    
40. AOYAMA R, Takano H, Kobayashi Y, Kitamura M, et al
    Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.
    PLoS One. 2017;12:e0188479.
    PubMed     Text format     Abstract available
    
    
    January 2016
41. LIU J, Li H, Liu Z, Wu Q, et al
    Complete Preoperative Evaluation of Pulmonary Atresia with Ventricular Septal Defect with Multi-Detector Computed Tomography.
    PLoS One. 2016;11:e0146380.
    PubMed     Text format     Abstract available
    
    
    
42. TSELIOU E, Kanazawa H, Dawkins J, Gallet R, et al
    Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology.
    PLoS One. 2016;11:e0144523.
    PubMed     Text format     Abstract available
    
    
    
43. SHIMONI S, Bar I, Meledin V, Derazne E, et al
    Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic Stenosis.
    PLoS One. 2016;11:e0148766.
    PubMed     Text format     Abstract available
    
    
    
44. PROTHMANN M, von Knobelsdorff-Brenkenhoff F, Topper A, Dieringer MA, et al
    High Spatial Resolution Cardiovascular Magnetic Resonance at 7.0 Tesla in Patients with Hypertrophic Cardiomyopathy - First Experiences: Lesson Learned from 7.0 Tesla.
    PLoS One. 2016;11:e0148066.
    PubMed     Text format     Abstract available
    
    
    
45. GILLIS K, Bala G, Roosens B, Remory I, et al
    Quantification of Calcium Amount in a New Experimental Model: A Comparison between Ultrasound and Computed Tomography.
    PLoS One. 2016;11:e0148904.
    PubMed     Text format     Abstract available
    
    
    
46. CHEN Q, Gao H, Hua Z, Yang K, et al
    Outcomes of Surgical Repair for Persistent Truncus Arteriosus from Neonates to Adults: A Single Center's Experience.
    PLoS One. 2016;11:e0146800.
    PubMed     Text format     Abstract available
    
    
    
47. RAMMOS C, Zeus T, Balzer J, Kubatz L, et al
    Percutaneous Mitral Valve Repair in Mitral Regurgitation Reduces Cell-Free Hemoglobin and Improves Endothelial Function.
    PLoS One. 2016;11:e0151203.
    PubMed     Text format     Abstract available
    
    
    
48. HA H, Kim GB, Kweon J, Huh HK, et al
    Turbulent Kinetic Energy Measurement Using Phase Contrast MRI for Estimating the Post-Stenotic Pressure Drop: In Vitro Validation and Clinical Application.
    PLoS One. 2016;11:e0151540.
    PubMed     Text format     Abstract available
    
    
    
49. CASHMAN TJ, Josowitz R, Johnson BV, Gelb BD, et al
    Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.
    PLoS One. 2016;11:e0146697.
    PubMed     Text format     Abstract available
    
    
    
50. ZHANG C, Liu R, Yuan J, Cui J, et al
    Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
    PLoS One. 2016;11:e0146572.
    PubMed     Text format     Abstract available
    
    
    
51. WOHRLE J, Gonska B, Rodewald C, Seeger J, et al
    Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis-Impact of Valve Size in a Single Center Experience.
    PLoS One. 2016;11:e0151247.
    PubMed     Text format     Abstract available
    
    
    
52. BERISHA S, Han J, Shahid M, Han Y, et al
    Measurement of Myocardial T1rho with a Motion Corrected, Parametric Mapping Sequence in Humans.
    PLoS One. 2016;11:e0151144.
    PubMed     Text format     Abstract available
    
    
    
53. LEE TW, Kowalski S, Falk K, Maguire D, et al
    High Spinal Anesthesia Enhances Anti-Inflammatory Responses in Patients Undergoing Coronary Artery Bypass Graft Surgery and Aortic Valve Replacement: Randomized Pilot Study.
    PLoS One. 2016;11:e0149942.
    PubMed     Text format     Abstract available
    
    
    
54. HE G, Tan W, Wang B, Chen J, et al
    Increased M1 Macrophages Infiltration Is Associated with Thrombogenesis in Rheumatic Mitral Stenosis Patients with Atrial Fibrillation.
    PLoS One. 2016;11:e0149910.
    PubMed     Text format     Abstract available
    
    
    
55. HORN P, Erkilet G, Veulemans V, Kropil P, et al
    Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis.
    PLoS One. 2016;11:e0151499.
    PubMed     Text format     Abstract available
    
    
    
56. PRAKASH S, Kuang SQ, Regalado E, Guo D, et al
    Recurrent Rare Genomic Copy Number Variants and Bicuspid Aortic Valve Are Enriched in Early Onset Thoracic Aortic Aneurysms and Dissections.
    PLoS One. 2016;11:e0153543.
    PubMed     Text format     Abstract available
    
    
    
57. AL-RASHID F, Kahlert P, Selge F, Hildebrandt H, et al
    Risk Assessment of Patients Undergoing Transfemoral Aortic Valve Implantation upon Admission for Post-Interventional Intensive Care and Surveillance: Implications on Short- and Midterm Outcomes.
    PLoS One. 2016;11:e0167072.
    PubMed     Text format     Abstract available
    
    
    January 2015
58. CASALINO R, Tarasoutchi F, Spina G, Katz M, et al
    EuroSCORE models in a cohort of patients with valvular heart disease and a high prevalence of rheumatic fever submitted to surgical procedures.
    PLoS One. 2015;10:e0118357.
    PubMed     Text format     Abstract available
    
    
    
59. HAGEN CM, Aidt FH, Havndrup O, Hedley PL, et al
    Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.
    PLoS One. 2015;10:e0124540.
    PubMed     Text format     Abstract available
    
    
    
60. MADEO A, Piras P, Re F, Gabriele S, et al
    A new 4D trajectory-based approach unveils abnormal LV revolution dynamics in hypertrophic cardiomyopathy.
    PLoS One. 2015;10:e0122376.
    PubMed     Text format     Abstract available
    
    
    
61. CHEN C, Zhao ZG, Liao YB, Peng Y, et al
    Impact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0119817.
    PubMed     Text format     Abstract available
    
    
    
62. SHUVY M, Abedat S, Mustafa M, Duvdevan N, et al
    Cellular Changes during Renal Failure-Induced Inflammatory Aortic Valve Disease.
    PLoS One. 2015;10:e0129725.
    PubMed     Text format     Abstract available
    
    
    
63. LEE JM, Park SJ, Lee SP, Park E, et al
    Gender difference in ventricular response to aortic stenosis: insight from cardiovascular magnetic resonance.
    PLoS One. 2015;10:e0121684.
    PubMed     Text format     Abstract available
    
    
    
64. HE B, Ge H, Yang F, Sun Y, et al
    A Novel Method in the Stratification of Post-Myocardial-Infarction Patients Based on Pathophysiology.
    PLoS One. 2015;10:e0130158.
    PubMed     Text format     Abstract available
    
    
    
65. LANCELLOTTI P, Dulgheru R, Magne J, Henri C, et al
    Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis.
    PLoS One. 2015;10:e0138940.
    PubMed     Text format     Abstract available
    
    
    January 2014
66. MOSER B, Megerle A, Bekos C, Janik S, et al
    Local and Systemic RAGE Axis Changes in Pulmonary Hypertension: CTEPH and iPAH.
    PLoS One. 2014;9:e106440.
    PubMed     Text format     Abstract available
    
    
    
67. ZHANG S, Yang ZG, Sun JY, Wen LY, et al
    Assessing right ventricular function in patients with hypertrophic cardiomyopathy with cardiac MRI: correlation with the New York Heart Function Assessment (NYHA) classification.
    PLoS One. 2014;9:e104312.
    PubMed     Text format     Abstract available
    
    
    
68. KOIVISTO E, Jurado Acosta A, Moilanen AM, Tokola H, et al
    Characterization of the regulatory mechanisms of activating transcription factor 3 by hypertrophic stimuli in rat cardiomyocytes.
    PLoS One. 2014;9:e105168.
    PubMed     Text format     Abstract available
    
    
    
69. HELLHAMMER K, Zeus T, Balzer J, van Hall S, et al
    Safety and Efficacy of Percutaneous Mitral Valve Repair Using the MitraClip(R) System in Patients with Diabetes Mellitus.
    PLoS One. 2014;9:e111178.
    PubMed     Text format     Abstract available
    
    
    
70. DE BACKER O, Arnous S, Lonborg J, Brooks M, et al
    Recovery from anemia in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation - prevalence, predictors and clinical outcome.
    PLoS One. 2014;9:e114038.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: